<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nottingham_Demonstrate skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nottingham/Demonstrate</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><MENU class="main-menu"><MENUITEM class="header"><A href="/Team:Nottingham" style="color:inherit"><EM>Clostridium</EM> dTox</A></MENUITEM><MENU class="right menu"><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Project">Project</SPAN></MENUITEM></MENU></MENU></P><DIV class="dropdown-content"><A href="/Team:Nottingham/Project#description">
			    Project description
			  </A><A href="/Team:Nottingham/Project#abstract">
			    Abstract
			  </A></DIV><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Human_Practices">Human Practices</SPAN><DIV class="dropdown-content"><A href="/Team:Nottingham/Human_Practices#overview">
					Overview
				</A><A href="/Team:Nottingham/Human_Practices#silver">
					Silver
				</A><A href="/Team:Nottingham/Human_Practices#gold">
					Gold
				</A><A href="/Team:Nottingham/Human_Practices#safety">
					Safety and Ethics
				</A></DIV></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Public_Engagement">Public Engagement</SPAN><DIV class="dropdown-content"><A href="/Team:Nottingham/Public_Engagement#discovery">
					Discovery day
				</A><A href="/Team:Nottingham/Public_Engagement#school-workshops">
					School workshops
				</A><A href="/Team:Nottingham/Public_Engagement#media">
					Media
				</A></DIV></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Lab">Lab
			<DIV class="dropdown-content"><A href="/Team:Nottingham/Lab#ideas">
					Ideas
				</A><A href="/Team:Nottingham/Lab#design">
					Design
				</A><A href="/Team:Nottingham/Lab#results">
					Results
				</A><A href="/Team:Nottingham/Lab#conclusion">
					Conclusion
				</A><A href="/Team:Nottingham/Lab#future-work">
					Future Work
				</A><A href="/Team:Nottingham/Lab#interlab">
					Interlab
				</A><A href="/Team:Nottingham/Lab#labfolder">
					Labfolder
				</A></DIV></SPAN></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Model">Modelling
			<DIV class="dropdown-content" style="min-width:300px"><A href="/Team:Nottingham/Model#intro">
					Introduction
				</A><A href="/Team:Nottingham/Model#summary">
					Summary
				</A><A href="/Team:Nottingham/Model#lytic-phage-models">
					Lytic Phage Models
				</A><A href="/Team:Nottingham/Model#temperate-phage-models">
					Temporate Phage Models
				</A><A href="/Team:Nottingham/Model#comparison-of-models">
					Comparsion of all three models
				</A><A href="/Team:Nottingham/Model#methodology">
					Methodology
				</A><A href="/Team:Nottingham/Model#parameters">
					Parameters
				</A><A href="/Team:Nottingham/Model#references">
					References
				</A></DIV></SPAN></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Collaborations">Collaborations
			<DIV class="dropdown-content" style="min-width:300px"><A href="/Team:Nottingham/Collaborations#warwick">
					The University of Warwick 
				</A><A href="/Team:Nottingham/Collaborations#biomarvel">
					Team BioMarvel- Korea
				</A><A href="/Team:Nottingham/Collaborations#warwick-and-imperial">
					The University of Warwick and Imperial College London
				</A><A href="/Team:Nottingham/Collaborations#meetups">
					UK Meetups
				</A></DIV></SPAN></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Achievements">Achievements
			<DIV class="dropdown-content"><A href="/Team:Nottingham/Achievements#medal-criteria">
					Medal Criteria
				</A><A href="/Team:Nottingham/Achievements#parts">
					Parts
				</A><A href="/Team:Nottingham/Achievements#improved-parts">
					Improved parts
				</A><A href="/Team:Nottingham/Achievements#demonstrate">
					Demonstrate
				</A><A href="/Team:Nottingham/Achievements#conclusion">
					General conclusion
				</A></DIV></SPAN></MENUITEM><MENUITEM class="dropdown dropdowntn"><SPAN class="link" data-url="/Team:Nottingham/Team">Team
			<DIV class="dropdown-content" style="min-width:200px"><A href="/Team:Nottingham/Team#Students">
					Students
				</A><A href="/Team:Nottingham/Team#Supervisors">
					Supervisors
				</A><A href="/Team:Nottingham/Team#Principal-investigators">
					Principal Investigators
				</A></DIV></SPAN></MENUITEM><A href="/Team:Nottingham/Attributions"><MENUITEM class="dropdown dropdowntn">
			Attributions
		</MENUITEM></A><SECTION><DIV class="ui blue message"><DIV class="ui small header">This is part of the Achievements page!</DIV><P>
			To meet medal criteria, and to make life for judges easier, we have extracted this part of the demonstrate page.
			<A class="ui button" href="/Team:Nottingham/Achievements#demonstrate">Original page</A></P></DIV><DIV class="ui segment"><H2>Demonstrate</H2><P>Project goal: to genetically modify a phage capable of suppressing toxin production in <EM>C. difficile</EM> by integrating our genetic constructs into its genome. We are using a phage known to infect strains of <EM>C. difficile</EM> called phiSBRC. The genome of phiSBRC will be packaged with constructs to suppress toxin production either via a CRIPSRi (dead-Cas9) approach or via asRNA.
The asRNA parts were created to target the two well characterised <EM>C. difficile</EM> toxins, TcdA and TcdB. These toxins are responsible for the characteristic symptoms of <EM>C. difficile</EM> infection. The parts were constructed in such a way that they targeted both toxins simultaneously because both toxins have been shown to have independent roles.</P><P>The asRNA parts are downstream of a PCac_thl promoter and a PCsp_fdx promoter. Between, the promoter-asRNA pairs, there is a transcriptional terminator (fdx). As a result of GusA and GFP assays, we determined that PCac_thl promoter was the strongest promoter, followed by PCsp_fdx promoter in <EM>C. difficile</EM>. Together, the basic parts produced our composite part.</P><P>Longer asRNAs give a higher degree of suppression but generally have more unwanted off-target effects which could be due to increased similarity with other mRNA transcripts. As the amount of DNA that phiSBRC can package is limited shorter asRNAs would be more desirable. As a result, we created two versions of the composite part which we named ‘asRNA Construct One’ (BBa_K2715007) and ‘asRNA Construct Two’ (BBa_K2715008). For each part we varied the length so that ‘asRNA Construct Two’ had 26 more base pairs complementary to the toxin gene mRNA than ‘asRNA Construct One’. ‘asRNA Construct One’ has a binding region of 24bp while ‘asRNA Construct Two’ has a binding region of 50bp.</P><P>We were able to directly measure the effect of our constructs on toxin production and toxicity of the <EM>C. difficile</EM> supernatant. We cloned the constructs into a plasmid vector suitable for transforming <EM>C. difficile</EM>. Supernatant cytotoxicity was compared between <EM>C. difficile</EM> containing the vectors with our constructs (coding for the asRNA) and wild-type <EM>C. difficile</EM> using African green monkey kidney epithelial ‘Vero’ cells. Supernatant samples from <EM>C. difficile</EM> cultures over five days were obtained for specific times points and the sterile supernatants applied to the Vero cells. Cytotoxicity was estimated using a lactate dehydrogenase (LDH) assay. Our results suggest that ‘asRNA Construct One’ reduces the rate of toxin production by 80% whilst asRNA Construct Two reduces it by 85% over wild type.</P><DIV class="ui two column grid"><DIV class="ui column"><H6><STRONG>Cytotoxicity of <EM>C. difficile</EM> supernatants.</STRONG>The graph shows supernatant cytotoxicity over a period of 120 hours. There is considerably less toxin production by <EM>C. difficile</EM> containing asRNA construct 1 and <EM>C. difficile</EM> containing asRNA construct 2 than by wild type <EM>C. difficile</EM>.</H6></DIV><DIV class="ui column"><H6><STRONG>Rate of toxin production.</STRONG><EM>C. difficile</EM> containing asRNA construct 1 and <EM>C. difficile</EM> containing asRNA construct 2 exhibit a significantly slower rate of toxin production than wild type <EM>C. difficile</EM>. Here we see an 80% reduction in the rate of toxin production by <EM>C. difficile</EM> containing asRNA construct 1 and an 85% reduction in the rate of toxin production by <EM>C. difficile</EM> containing asRNA construct 2.</H6></DIV></DIV></DIV></SECTION><DIV class="ui container PageCard_container_1ok2Drx5q2skrrX8ItRY6X"><A href="/Team:Nottingham/test/sponsors" class="ui fluid basic button">About our sponsors</A></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>